Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
Radiofrequency ablation (RFA) and hepatic resection are main treatments for early stage
hepatocellular carcinoma. Many randomized controlled trials found these two treatments have
similar short term overall survival. However, hepatic resection is associated with higher
long-term overall survival. These results reveal that tumor recurrence rate after RFA is
higher than that after hepatic resection. And minimal residual tumor may exist after RFA.
Radiotherapy after RFA may be effective to prevent early tumor recurrence.